(η(5)-Penta­methyl­cyclo­penta­dien­yl)(η(6)-p-toluene­sulfonamide)ruthenium(II) tetra­phenyl­borate

The crystal structure of the title compound, [Ru(C(10)H(15))(C(7)H(9)NO(2)S)]C(24)H(20)B, has been determined as part of our investigation into the structural and biological properties of organometallic Ru(II)–arene–Cp* complex salts of the type [R-PhRuCp*](+)·X (−) (where Cp* is penta­methyl­cyclo­...

Descripción completa

Detalles Bibliográficos
Autores principales: Loughrey, Bradley T., Williams, Michael L., Poulsen, Sally-Ann, Healy, Peter C.
Formato: Texto
Lenguaje:English
Publicado: International Union of Crystallography 2008
Materias:
Metal-Organic Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2960125/
https://www.ncbi.nlm.nih.gov/pubmed/21581173
http://dx.doi.org/10.1107/S1600536808037689
Descripción
Sumario:The crystal structure of the title compound, [Ru(C(10)H(15))(C(7)H(9)NO(2)S)]C(24)H(20)B, has been determined as part of our investigation into the structural and biological properties of organometallic Ru(II)–arene–Cp* complex salts of the type [R-PhRuCp*](+)·X (−) (where Cp* is penta­methyl­cyclo­penta­diene). Tethering the RuCp* group to the benzene ring of p-toluene­sulfonamide results in only minor changes to the mol­ecular geometry of the sulfonamide, but, together with crystallization as the [BPh(4)](−) salt, effectively blocks involvement of the sulfonamide group in N—H⋯O hydrogen-bonding networks.

Ejemplares similares